| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Duker Jay S. | President and CEO, Director | C/O EYEPOINT PHARMACEUTICALS, INC., 480 PLEASANT STREET, WATERTOWN | /s/ Ron Honig, Attorney-in-Fact | 11 Jul 2025 | 0001630864 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EYPT | Common Stock | Options Exercise | $0 | +16,667 | +1690% | $0.000000 | 17,653 | 10 Jul 2025 | Direct | |
| transaction | EYPT | Common Stock | Tax liability | $85,029 | -7,688 | -44% | $11.06 | 9,965 | 10 Jul 2025 | Direct | F1 |
| holding | EYPT | Common Stock | 99,165 | 10 Jul 2025 | By Family Trust | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EYPT | Restricted Stock Units | Options Exercise | $0 | -16,667 | -50% | $0.000000 | 16,667 | 10 Jul 2025 | Common Stock | 16,667 | $0.000000 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units. |
| F2 | These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F3 | The restricted stock units vests in three ratable annual installments beginning July 10, 2024. |